News

Healios made poster presentations of our research results of joint research with Thomas Jefferson University on the efficacy of eNK cells, which Healios and Akatsuki Therapeutics are jointly researching and developing, in metastatic uveal melanoma at AACR (American Association of Cancer Research) Annual Meeting 2026 in San Diego, California from April 17 to 22, 2026.

Please make use of this page to view the posters of the abstracts.

Session: Immunology; Alternative Cell Type and in Situ Cell Therapies

Title: Anti-tumor activity of engineered iPSC-derived NK cells against metastatic uveal　melanoma cells

Presenter: Nadia Anikeeva¹, Tong Zhang¹, Sota Deguchi¹, Sergei Koshkin¹, Masashi Yamada², Kouichi, Tamura², Hironobu Kimura², Vitali Alexeev³, Yuri Sykulev¹, Takami Sato³ and Mizue Terai³

Presenter’s Affiliation:

1) Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson　University Philadelphia, PA USA

2) Kobe Research institute, HEALIOS K.K. Kobe, Japan

3) Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University Philadelphia, PA USA